Published

Treatment-Resistant Depression: A Comprehensive Insight of Ketamine Infusion Therapy, Transcranial Magnetic Stimulation (TMS), and Psychedelic-Assisted Psychotherapy

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Annals of Punjab Medical College
Date: 2024-12-31
Source: OpenAlex
DOI: 10.29054/apmc/2024.1658
PubMed: Unavailable

Authors

Mohammad Ali Urbah Viqar

Watch author

Derived topics and classifications

psilocybin Depression Receptor Pharmacology Clinical Trial Systematic Review Review Article Case Report Observational Study Treatment-Resistant Depression Systematic Review

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Treatment-Resistant Depression: A Comprehensive Insight of Ketamine Infusion Therapy, Transcranial Magnetic Stimulation (TMS), and Psychedelic-Assisted Psychotherapy2024-12-31

Related papers

Psychedelic renaissance: A renewed focus on the clinical utility of hallucinogensPsychiatry and Clinical Neurosciences Reports · 2024-05-16 Evaluating the Risk of Psilocybin for the Treatment of Bipolar Depression: A Review of the Research Literature and Published Case StudiesmedRxiv · 2021-04-07 Clinical treatment of cluster headache with the serotonergic indoleamine psychedelics psilocybin and LSD and with ketamine: A case seriesCephalalgia Reports · 2025-05-01 A suicide attempt following psilocybin ingestion in a patient with no prior psychiatric historyPsychiatry Research Case Reports · 2023-04-26 Anhedonia: Current and future treatments.PCN reports: psychiatry and clinical neurosciences · 2025-03-01 Psilocybin-Based Breakthroughs in Natural MedicineCase Reports and Reviews · 2023-04-30 New Psychoactive Substances (NPS), Psychedelic Experiences and Dissociation: Clinical and Clinical Pharmacological IssuesCurrent Addiction Reports · 2019-04-22 Contribution of the Serotonin 5-HT2A Receptor to the Therapeutic Effect of Psilocin on Social Behavior Deficits in Mice Repeatedly Exposed to Social Defeat StressNeuropsychopharmacology Reports · 2026-09-01